Pleomorphic carcinoma of the breast: clinicopathological analysis of 26 cases of an unusual high‐grade phenotype of ductal carcinoma
Authors:
- 1 June 2000
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 36 (6) , 505-514
Abstract
Aims: Pleomorphic carcinoma is a poorly described entity whose phenotype is not well recognized as within the morphological spectrum of breast carcinoma. The purpose of this report is to describe the clinicopathological features of this tumour, and to promote its recognition as an unusual high‐grade morphological variant of mammary ductal carcinoma.Methods and results: Histological slides of breast carcinomas (N = 64) coded between 1978 and 1995 as having pleomorphic or anaplastic features were reviewed. Pleomorphic carcinoma (N = 26) was diagnosed when ≥ 50% of the tumour manifested a pleomorphic cell population (> sixfold variation in nuclear size). Tumours of lobular origin were excluded. All neoplasms occurred in women with a mean age of 53 years. Patients underwent biopsy and/or mastectomy (n = 24) or lumpectomy (n = 2). The tumours' mean size was 54 mm. All were high‐grade neoplasms. The pleomorphic cell population comprised 50–100% of the tumour; 31% had a prominent spindled morphology. Fifty‐eight per cent of the tumours were initially misclassified by referring pathologists as sarcomas or carcinomas, possibly metastatic. Adjacent DCIS or a transition to classic ductal carcinoma was present in 73%. Five (19%) patients were stage I and three (12%) had stage IV disease. Axillary dissections yielded ≥ 3 (mean 7.2) positive lymph nodes in 52%. Most (68%) tumours were aneuploid; a high S‐phase (> 10%) was present in 63%. All neoplasms were ER negative and all but one were PR negative. p53 expression was present in 71%; none expressed bcl‐2. c‐erbB‐2 was detected in four (19%) node‐positive and in 0 (0%) node‐negative cases (P = 0.01). Of 16 patients with follow‐up, 6 (38%) were disease‐free (mean, 74 months), four (25%) alive with disease (mean, 33 months) and six (38%) dead of disease at a mean of 22 months.Conclusions: Pleomorphic carcinoma is a prognostically unfavourable lesion and represents the extreme end of the morphological spectrum of grade III infiltrating ductal carcinoma.Keywords
This publication has 19 references indexed in Scilit:
- Giant Cells in anaplastic mammary carcinoma of the dog and catJournal of Comparative Pathology, 1993
- Pleomorphic variant of invasive lobular carcinoma of the breastHuman Pathology, 1992
- Aspiration cytodiagnosis of breast carcinoma in pregnancy and lactation with immunohistochemical and electron microscopic study of an unusual mammary malignancy with pleomorphic giant cellsDiagnostic Cytopathology, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Modified Methodology to Improve Flow Cytometric Dna Histograms from Paraffin-Embedded MaterialStain Technology, 1990
- Primary breast sarcoma: A review of 33 cases with immunohistochemistry and prognostic factorsBreast Cancer Research and Treatment, 1989
- Metaplastic Carcinoma of the Breast : A Clinicopathologic Study of 29 PatientsAmerican Journal of Surgical Pathology, 1987
- Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.Journal of Histochemistry & Cytochemistry, 1983
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Mammary Carcinoma with Osteoclast-like Giant Cells: A Study of Eight Cases with Follow-up DataAmerican Journal of Clinical Pathology, 1979